Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | FAZ053 |
Trade Name | |
Synonyms | FAZ-053|FAZ 053 |
Drug Descriptions |
FAZ053, is a monoclonal antibody against CD274 (PD-L1) that inhibits binding to the PDCD1 (PD1) receptor, potentially resulting in enhanced anti-tumor immune response (NCI Drug Dictionary). |
DrugClasses | Immune Checkpoint Inhibitor 149 PD-L1/PD-1 antibody 121 |
CAS Registry Number | NA |
NCIT ID | C131537 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
FAZ053 | FAZ053 | 0 | 1 |
FAZ053 + Spartalizumab | FAZ053 Spartalizumab | 0 | 1 |